- On-Demand
Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer
- Available: April 27, 2022 —
- April 26, 2023
- Credit: 0.50hr(s)
- Credit Types: ABIM, CME, MOC, NCPD
- Therapeutic Areas: Endometrial Cancer, Gynecology, Oncology
- Specialties: Endometrial Cancer, Gynecologic Cancer, Oncology
- Location: Internet Enduring Activity
Course Description
In this activity, an expert in oncology discusses the role of immune checkpoint inhibitors in the care of patients with recurrent and advanced endometrial cancer.